Allotment of 40,000 Equity Shares to Promoter upon conversion of Warrants into Equity Shares
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Fredun Pharmaceuticals has allotted 40,000 equity shares to promoter Mrs. Daulat Nariman Medhora after she paid the remaining 75% consideration on convertible warrants originally issued on December 29, 2025. The shares were allotted at Rs. 1,250 each (face value Rs. 10, premium Rs. 1,240), bringing in Rs. 3.75 crore to the company. All warrants have now been fully converted with none outstanding. The new shares will rank equally with existing equity shares and will be issued in dematerialized form.
This is a routine completion of a previously announced preferential warrant conversion by the promoter, signaling promoter confidence. The 0.01% increase in equity base is negligible, so no meaningful dilution for existing shareholders.